Azione NTLA INTELLIA THERAPEUTICS, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Intellia Therapeutics, Inc.

Azioni

NTLA

US45826J1051

Tempo reale stimato Cboe BZX
Altri mercati azionari
 19:23:32 11/09/2024 		Variaz. 5gg Var. 1 gen.
19,88 USD -1,22% Grafico intraday di Intellia Therapeutics, Inc. -7,19% -35,26%
08/08 La perdita netta Q2 di Intellia Therapeutics si allarga, il fatturato cala MT
08/08 Transcript : Intellia Therapeutics, Inc., Q2 2024 Earnings Call, Aug 08, 2024

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics Q2 Net Loss Widens, Revenue Falls
Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
Intellia Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2024 Earnings and Company Updates
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2024 Earnings and Company Updates
Intellia Therapeutics Receives Backing of UK Health Regulator to Conduct Trial of Gene Therapy
Intellia Therapeutics Receives Authorization to Initiate Phase 1/2 Clinical Trial of NTLA-3001 for the Treatment of Alpha-1 Antitrypsin Deficiency
Intellia Therapeutics, Inc. Receives Authorization to Initiate Phase 1/2 Clinical Trial of Ntla-3001 for the Treatment of Alpha-1 Antitrypsin Deficiency
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
Intellia Therapeutics, Inc.(NasdaqGM:NTLA) dropped from Russell 3000 Growth Index
Intellia Therapeutics, Inc.(NasdaqGM:NTLA) dropped from Russell 2000 Growth Index
Intellia Therapeutics, Inc.(NasdaqGM:NTLA) dropped from Russell 2500 Growth Index
Intellia Therapeutics, Inc.(NasdaqGM:NTLA) dropped from Russell Small Cap Comp Growth Index
Intellia Therapeutics, Inc.(NasdaqGM:NTLA) dropped from Russell 3000E Growth Index
Intellia Therapeutics Names Edward Dulac CFO
Intellia Therapeutics Announces CFO Transition
Intellia Therapeutics, Inc. Announces Executive Changes
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione NTLA
  4. Notizie Intellia Therapeutics, Inc.
  5. Altre lingue
Stati Uniti

MarketScreener is also available in this country: United States.

Switch edition
Rimanere sul sito del Paese attuale